The image depicts a photonic array wirelessly receiving power from a distant antenna.

These implantable devices act as a control system for genetically engineered cells that are programmed to release drugs in response to light. 

Patients with chronic diseases often require repetitive infusions or injections of drugs to manage their health status. The Anderson/Langer Labs are developing advanced therapeutic strategies to alleviate patient care. This type of bioelectronic ‘living’ device containing cells that manufacture medicine on demand represents a long-term treatment in a single implant, with wirelessly controlled dose control.